GSK walks away from $100M bet on Mersana STING ADC – Fierce Biotech

The pharma already has an FDA-approved monovalent vaccine for bird flu, which is designed to be stockpiled in case of a future pandemic. Finally, GSK …

Read More at Source.

Pumilo
Author: Pumilo